1 results match your criteria: "University Hospital of Tampere and University of Tampere Medical School[Affiliation]"
Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study.
Atherosclerosis
October 2010
Division of Emergency, University Hospital of Tampere and University of Tampere Medical School, Tampere, Finland.
Aim: Plasma asymmetric dimethylarginine (ADMA) is a novel risk factor for atherosclerosis and has been observed to associate with endothelial function in cross-section studies. In the present study our aim was to investigate whether plasma ADMA levels are predictive of brachial artery endothelial function in a prospective setting.
Methods And Results: Using ultrasound we measured brachial artery flow-mediated dilation (FMD) both in 2001 and 2007 in 1808 healthy subjects aged 24-39 years at baseline.